These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30980441)

  • 21. Three-Dimensional Electroanatomic Mapping System-Enhanced Cardiac Resynchronization Therapy Device Implantation: Results From a Multicenter Registry.
    Del Greco M; Maines M; Marini M; Colella A; Zecchin M; Vitali-Serdoz L; Blandino A; Barbonaglia L; Allocca G; Mureddu R; Marenna B; Rossi P; Vaccari D; Chianca R; Indiani S; DI Matteo I; Angheben C; Zorzi A
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):85-93. PubMed ID: 27862594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors and Long-Term Survival of Octogenarians and Nonagenarians Undergoing Transvenous Lead Extraction Procedures.
    Jacheć W; Polewczyk A; Segreti L; Bongiorni MG; Kutarski A
    Gerontology; 2021; 67(1):36-48. PubMed ID: 33242867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
    Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
    Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complications and 1-year benefit of cardiac resynchronization therapy in patients over 75 years of age - Insights from the German Device Registry.
    Köbe J; Andresen D; Maier S; Stellbrink C; Kleemann T; Gonska BD; Reif S; Hochadel M; Senges J; Eckardt L
    Int J Cardiol; 2017 Feb; 228():784-789. PubMed ID: 27898337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure.
    Imamura T; Kinugawa K; Nitta D; Komuro I
    Circ J; 2015; 79(11):2414-21. PubMed ID: 26376671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis associated with redo cardiac resynchronization therapy following complete device and lead extraction due to device-related infection.
    Seifert M; Moeller V; Arya A; Schau T; Hoelschermann F; Butter C
    Europace; 2018 May; 20(5):808-815. PubMed ID: 28398556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventricular electrical delay as a predictor of arrhythmias in patients with cardiac resynchronization implantable cardioverter defibrillator.
    Elsaid O; Gulati V; Tecson K; Friedman M; Kluger J
    Scand Cardiovasc J; 2018 Dec; 52(6):356-361. PubMed ID: 30570402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional interlead distance predicts response and outcomes after cardiac resynchronization therapy.
    Clementy N; Laborie G; Pierre B; Benhenda N; Babuty D; Fauchier L
    Arch Cardiovasc Dis; 2017 Nov; 110(11):590-598. PubMed ID: 28734687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
    Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transvenous Lead Extraction in Patients with Cardiac Implantable Device: The Impact of Systemic and Local Infection on Clinical Outcomes-An ESC-EHRA ELECTRa (European Lead Extraction Controlled) Registry Substudy.
    Diemberger I; Segreti L; Rinaldi CA; Svendsen JH; Kutarski A; Younis A; Laroche C; Leclercq C; Małecka B; Mitkowski P; Bongiorni MG; On Behalf Of The ELECTRa Investigators
    Biology (Basel); 2022 Apr; 11(4):. PubMed ID: 35453815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of multidisciplinary cardiac rehabilitation on the response to cardiac resynchronization therapy.
    Martens P; Jacobs G; Dupont M; Mullens W
    Cardiovasc Ther; 2018 Dec; 36(6):e12467. PubMed ID: 30239134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hybrid approach to cardiac resynchronization therapy.
    Quigley RL
    Ann Thorac Cardiovasc Surg; 2011; 17(3):273-6. PubMed ID: 21697789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome of patients with and without super-response to CRT-D.
    Franke J; Keppler J; Abadei AK; Bajrovic A; Meme L; Zugck C; Raake PW; Zitron E; Katus HA; Frankenstein L
    Clin Res Cardiol; 2016 Apr; 105(4):341-8. PubMed ID: 26497005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
    Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S
    Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.
    Sardu C; Barbieri M; Santamaria M; Giordano V; Sacra C; Paolisso P; Spirito A; Marfella R; Paolisso G; Rizzo MR
    Cardiovasc Diabetol; 2017 Jun; 16(1):75. PubMed ID: 28599667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II.
    Lawin D; Israel CW; Linde C; Normand C; Dickstein K; Lober C; Gitt AK; Hindricks G; Stellbrink C;
    Clin Res Cardiol; 2020 Jul; 109(7):832-844. PubMed ID: 31811440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.